Thursday, 12 January 2012

Protease inhibitor with therapeutic potential...

Dundee University researches have been busy researching Protease inhibitors and have recently filed patent on their last research. Protease inhibitors are agents that can stop splitting a protein into peptides and are used primarily in HIV/AIDS treatment.

The Dundee researchers state "Based on their importance in health and disease, the proteases of the endo-lysosomal pathway - particularly the cathepsins - have frequently been proposed as therapeutic targets. Effective pharmaceutical exploitation of the pathway has been prevented by the issue of redundancy - novel methods to overcome this challenge are required."